Another alliance of health care and AI signals why pharma stocks should be back in favor

Bristol Myers Squibb and Microsoft's new partnership aimed at accelerating early detection of lung cancer.

Another alliance of health care and AI signals why pharma stocks should be back in favor

Published Tue, Jan 20 20263:31 PM EST